Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1898)
NICE advice (321)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (791)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (253)
Apply filters
Showing 1511 to 1520 of 2417
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer
TA951
7 February 2024
7 February 2024
Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer
TA946
17 January 2024
17 January 2024
Older people with social care needs and multiple long-term conditions
NG22
4 November 2015
4 November 2015
Older people: independence and mental wellbeing
NG32
17 December 2015
17 December 2015
Omalizumab for previously treated chronic spontaneous urticaria
TA339
8 June 2015
8 June 2015
Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)
TA678
24 February 2021
24 February 2021
Omalizumab for treating severe persistent allergic asthma
TA278
24 April 2013
24 April 2013
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
TA365
25 November 2015
25 November 2015
Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy
HST24
19 April 2023
19 April 2023
Onasemnogene abeparvovec for treating spinal muscular atrophy
HST15
7 July 2021
19 April 2023
Previous page
1
…
150
151
Current page
152
153
154
…
242
Page
152
of
242
Next page
Results per page
10
25
50
All
Back to top